Circadian Rhythms: Shedding new light on circadian clocks

  1. Maud Demarque  Is a corresponding author
  2. Ueli Schibler  Is a corresponding author
  1. University of Geneva, Switzerland

Circadian clocks adapt the physiology of many different species to recurring changes in their environments—notably, to 24-hour cycles of daylight and darkness—in a proactive manner. In mammals, the circadian timing system is composed of a master pacemaker in the suprachiasmatic nucleus, which is located in the brain, and subsidiary clocks in virtually all body cells. However, these circadian clocks can measure time only approximately—the Latin words circa diem mean ‘about a day'—so they must be synchronized daily to ensure that they remain in time with the 24-hour day.

The process of synchronization begins with electrical signals from the retina causing an influx of calcium ions into postsynaptic neurons in the suprachiasmatic nucleus. This influx activates various protein kinases that increase the activity of a number of immediate early transcription factors which, in turn, enhance the expression of genes ensuring that the master pacemaker remains synchronized. The suprachiasmatic nucleus then synchronizes the subsidiary clocks via a large variety of signalling pathways that depend on feeding cycles, hormones, body temperature rhythms and neuronal cues (Dibner et al., 2010).

The molecular circuitry responsible for maintaining circadian rhythms is composed of two interlocked feedback loops. The major loop relies on two transcription factors, CLOCK and BMAL1, forming a complex that stimulates the expression of target genes by binding to regions of DNA called Enhancer-boxes (E-boxes) that are associated with the target genes (Figure 1). Four of these target genes—Per1, Per2, Cry1 and Cry2—produce proteins that counteract the effects of the CLOCK:BMAL1 complex and, as a consequence, establish a negative feedback loop that actually suppresses their own expression (Lowrey and Takahashi, 2000; Reppert and Weaver, 2001). In the other loop, CLOCK and BMAL1 control the transcription of the genes that code for various nuclear receptors that govern the cyclic transcription of the Bmal1 and Clock genes (Preitner et al., 2002; Ueda et al., 2002; Bugge et al., 2012; Cho et al., 2012). The circadian system also depends on a large number of post-translational processes. The overall effect of these two feedback loops, plus the various post-translational processes, is to determine the intrinsic period of the circadian cycle, which is subsequently synchronized to a period of 24 hours as described above.

Model for the role of two transcription factors—CLOCK and USF1—in the circadian clock.

(A) In wild-type mice, the CLOCK:BMAL1 complex binds to E-box sites on the genome with a much higher affinity than USF1, so they occupy the majority of E-box sites (as denoted by the relative thicknesses of the vertical arrows). This means that CLOCK:BMAL1 complexes also have a much larger role in the transcription of the gene associated with the E-box (as denoted by the relative thicknesses of the horizontal arrows). (B) In some ClockΔ19 mutant mice (such as heterozygous C57BL/6J mice), both the CLOCK:BMAL1 and CLOCKΔ19:BMAL1 complexes bind to E-box sites, but the latter is not able to drive transcription (denoted by the red X). In these mice the total level of transcription driven by the CLOCK:BMAL1 complex and USF1 is not sufficient to drive normal circadian gene expression, which results in the period of the circadian cycle becoming longer. (C) Other ClockΔ19 mutant mice (such as heterozygous BALB/cJ mice) produce higher levels of USF1 than C57BL/6J mice (denoted by the thick arrow pointing down), and the total level of transcription driven by the CLOCK:BMAL1 complex and USF1 is high enough to drive normal circadian gene expression.

In the 1990s, researchers led by Joseph Takahashi—then at Northwestern University, now at the University of Texas Southwestern (UTSW) Medical Center—identified a semi-dominant mutation in the Clock gene, ClockΔ19, that lengthened the circadian period in mice of the C57BL/6J strain, and caused most homozygous mutant mice to become arrhythmic when exposed to constant darkness over an extended time period (Antoch et al., 1997; King et al., 1997). Although the CLOCKΔ19 mutant protein can still form a complex with BMAL1 that is capable of binding to DNA (albeit with reduced affinity), it is not able to activate transcription. Takahashi and colleagues also noted that the penetrance of the clock mutant phenotype (that is, the fraction of mice in which these traits were evident) was much higher in some strains than in others. In order to identify the genes that might be responsible for this difference between strains, they performed a complex trait analysis on nearly 200 hybrid mice and identified 14 loci associated with possible ClockΔ19 modulator genes (Shimomura et al., 2001).

Now, in eLife, Takahashi and co-workers—including Kazuhiro Shimomura of Northwestern University as first author—report that they have extended this work by identifying a transcription factor that suppresses the ClockΔ19 mutation in one strain of these mice (a strain called BALB/cJ). To this end they used a combination of two genetic techniques (quantitative trait locus and haplotype block mapping) to narrow down the region of the genome that is responsible for the suppression of this mutation: this region is a DNA segment encompassing about 900 kilo base pairs and 22 protein encoding genes. Seven of these genes were expressed in the same tissues as Clock. However, only one of them, Usf1 (which codes for a transcription factor called upstream transcription factor 1), was more active in mice in which the ClockΔ19 mutation was suppressed. Moreover, a moderate overexpression of USF1 suppressed the ClockΔ19 mutant phenotype in C57BL/6J mice. This provides compelling evidence for the scenario proposed by the authors, namely that the increased accumulation of USF1 in BALB/cJ mice accounts for the suppression of the ClockΔ19 mutant phenotype in this mouse strain.

The region responsible for increased transcription of the Usf1 gene in BALB/cJ mice has been mapped to a DNA fragment containing about 1000 base pairs. Importantly, the analysis of protein-DNA complexes by biochemical assays and chromatin-immunoprecipitation experiments demonstrated that USF1 and CLOCK:BMAL1 can indeed bind to the same E-box motifs.

The intrinsic period of the circadian cycle can be determined by keeping the mice under conditions of constant darkness. Such experiments reveal that Usf1 knockout mice and wild-type mice have similar intrinsic periods. Thus, USF1 does not contribute significantly to determining the period of the circadian cycle in wild-type mice. However, compared to wild-type mice, the mutant mice are less active overall. Moreover, their levels of activity vary much less over the circadian cycle. This suggests that USF1 contributes to the robustness of circadian behaviour.

Based on an extensive body of genetic and biochemical work, Takahashi, Shimomura and co-workers have shown that USF1 is involved in the fine-tuning of the circadian system. Moreover, as USF1 does not appear to require BMAL1 to recognize E-box DNA elements, it is likely that the CLOCK:BMAL1 complex and USF1 cannot bind their cognate DNA elements at the same time, at least in target genes that depend on a single E-box (Figure 1). Shimomura et al. thus suggest that USF1 may facilitate the binding of CLOCK:BMAL1 complexes by maintaining an open chromatin configuration around the relevant E-box.

In addition to the impact that this work will have on research into circadian rhythms, it also addresses an issue—penetrance—that is of utmost importance for complex genetics. A large fraction of illnesses, including cardiovascular dysfunction, metabolic syndrome, cancer and degenerative brain diseases, are caused by complex interactions between multiple alleles and modifier genes. However, only a few of the genes that influence the penetrance of a mutant allele have been cloned and dissected at the molecular level. The work of Shimomura et al. provides a convincing example for how genetic penetrance can be modulated in different genetic backgrounds. Indeed, it goes far beyond the analysis of circadian clocks and is relevant for a large community of life scientists interested in genetic networks.

References

Article and author information

Author details

  1. Maud Demarque

    Department of Molecular Biology, University of Geneva, Geneva, Switzerland
    For correspondence
    maud.demarque@unige.ch
    Competing interests
    The authors declare that no competing interests exist.
  2. Ueli Schibler

    the Department of Molecular Biology, University of Geneva, Geneva, Switzerland
    For correspondence
    ueli.schibler@unige.ch
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: April 9, 2013 (version 1)

Copyright

© 2013, Demarque and Schibler

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 677
    views
  • 92
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Maud Demarque
  2. Ueli Schibler
(2013)
Circadian Rhythms: Shedding new light on circadian clocks
eLife 2:e00659.
https://doi.org/10.7554/eLife.00659

Further reading

    1. Genetics and Genomics
    Mohammad Alfatah, Jolyn Jia Jia Lim ... Frank Eisenhaber
    Research Article

    Uncovering the regulators of cellular aging will unravel the complexity of aging biology and identify potential therapeutic interventions to delay the onset and progress of chronic, aging-related diseases. In this work, we systematically compared genesets involved in regulating the lifespan of Saccharomyces cerevisiae (a powerful model organism to study the cellular aging of humans) and those with expression changes under rapamycin treatment. Among the functionally uncharacterized genes in the overlap set, YBR238C stood out as the only one downregulated by rapamycin and with an increased chronological and replicative lifespan upon deletion. We show that YBR238C and its paralog RMD9 oppositely affect mitochondria and aging. YBR238C deletion increases the cellular lifespan by enhancing mitochondrial function. Its overexpression accelerates cellular aging via mitochondrial dysfunction. We find that the phenotypic effect of YBR238C is largely explained by HAP4- and RMD9-dependent mechanisms. Furthermore, we find that genetic- or chemical-based induction of mitochondrial dysfunction increases TORC1 (Target of Rapamycin Complex 1) activity that, subsequently, accelerates cellular aging. Notably, TORC1 inhibition by rapamycin (or deletion of YBR238C) improves the shortened lifespan under these mitochondrial dysfunction conditions in yeast and human cells. The growth of mutant cells (a proxy of TORC1 activity) with enhanced mitochondrial function is sensitive to rapamycin whereas the growth of defective mitochondrial mutants is largely resistant to rapamycin compared to wild type. Our findings demonstrate a feedback loop between TORC1 and mitochondria (the TORC1–MItochondria–TORC1 (TOMITO) signaling process) that regulates cellular aging processes. Hereby, YBR238C is an effector of TORC1 modulating mitochondrial function.

    1. Genetics and Genomics
    2. Neuroscience
    Céline Petitgas, Laurent Seugnet ... Serge Birman
    Research Article

    Adenine phosphoribosyltransferase (APRT) and hypoxanthine-guanine phosphoribosyltransferase (HGPRT) are two structurally related enzymes involved in purine recycling in humans. Inherited mutations that suppress HGPRT activity are associated with Lesch–Nyhan disease (LND), a rare X-linked metabolic and neurological disorder in children, characterized by hyperuricemia, dystonia, and compulsive self-injury. To date, no treatment is available for these neurological defects and no animal model recapitulates all symptoms of LND patients. Here, we studied LND-related mechanisms in the fruit fly. By combining enzymatic assays and phylogenetic analysis, we confirm that no HGPRT activity is expressed in Drosophila melanogaster, making the APRT homolog (Aprt) the only purine-recycling enzyme in this organism. Whereas APRT deficiency does not trigger neurological defects in humans, we observed that Drosophila Aprt mutants show both metabolic and neurobehavioral disturbances, including increased uric acid levels, locomotor impairments, sleep alterations, seizure-like behavior, reduced lifespan, and reduction of adenosine signaling and content. Locomotor defects could be rescued by Aprt re-expression in neurons and reproduced by knocking down Aprt selectively in the protocerebral anterior medial (PAM) dopaminergic neurons, the mushroom bodies, or glia subsets. Ingestion of allopurinol rescued uric acid levels in Aprt-deficient mutants but not neurological defects, as is the case in LND patients, while feeding adenosine or N6-methyladenosine (m6A) during development fully rescued the epileptic behavior. Intriguingly, pan-neuronal expression of an LND-associated mutant form of human HGPRT (I42T), but not the wild-type enzyme, resulted in early locomotor defects and seizure in flies, similar to Aprt deficiency. Overall, our results suggest that Drosophila could be used in different ways to better understand LND and seek a cure for this dramatic disease.